YÇYeşim Kınacı Çimen

Yeşim Kınacı Çimen

*This is an algorithmically generated author record based on publicly available information.

Yeşim Kınacı Çimen has a total of 19 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Ongoing post-COVID-19 symptoms and complaints among healthcare professionals

    by Muhammet Burak Ozkan, Aysun Ozsahin, Nilufer Emre, Tamer Edirne, Yeşim Kınacı Çimen

    Introduction: Post-COVID-19 syndrome refers to the occurrence of symptoms lasting more than 4 weeks in individuals who have recovered from COVID-19. This study aims to investigate the post-COVID-19 symptoms in healthcare professionals. Methodology: This descriptive study included 166 healthcare professionals who had tested positive for COVID-19 via PCR at least four weeks prior and subsequently presented to the Family Medicine Clinic at Pamukkale University Training and Research Hospital. Participants` demographic data, medical history, COVID-19 history and ongoing or newly emerged complaints and symptoms were evaluated, and physical examinations were carried out and recorded on a patient information form. Blood tests were conducted, and the results were analyzed. Results: The most common post-COVID-19 symptoms and complaints observed in our study were difficulty in performing daily activities (32.5%; n = 54), fatigue (26.5%; n = 44), forgetfulness (25.9%; n = 43) and weakness (24.1%; n = 40), respectively. Smoking, alcohol use, hospitalization, the need for oxygen support and having comorbidities such as asthma, diabetes, hypertension and rheumatism were found to be associated with various post-acute symptoms. Post-acute symptoms were most frequently observed in individuals vaccinated with Sinovac (38.5%), followed by those who were unvaccinated (35.7%). Least symptoms were seen in individuals vaccinated with only Biontech (15.4%). Conclusions: The most common post-COVID-19 symptoms observed in our study were difficulty in performing daily activities, fatigue, forgetfulness and weakness. Having comorbidities was found to be associated with various post-COVID-19 symptoms.


  • Efficacy of Intravenous Paracetamol, Dexketoprofen, and Ibuprofen in Treating Headache Induced by Acute Migraine Attack

    by Şerife Örnek, Atakan Yılmaz, Alten Oskay, Aykut Kemancı, Mehmet Ulutürk, Yeşim Kınacı Çimen, Ezgi Demirözoğul, Murat Seyit, Mert Özen, İbRahim Türkçüer


  • Open Access

    Factors Affecting Admission Frequency and Compliance with Antihypertensive Treatment of Patients Presenting to the Emergency Department with Hypertensive Attack

    by Atakan Yılmaz, Üzeyir Çimen, Canan Uluoğlu, Yeşim Kınacı Çimen, Alten Oskay, Murat Seyit, Mert Özen, İbRahim Türkçüer, Gizem Oncel Yel, Mehmet Ulutürk, et al.

  • Open Access

    Comparative evaluation of the efficacy of intravenous paracetamol and ibuprofen on the treatment of tonsillopharyngitis with fever

    by Gizem Oncel, Atakan Yilmaz, Ramazan Sabirli, Yesim Kinaci Cimen, Mert Ozen, Murat Seyit, Ibrahim Turkcuer, Uzeyir Cimen

    OBJECTIVE: Tonsillopharyngitis is one of the constituents of upper respiratory tract infection (URTI). Fever is a URTI symptom requiring treatment due to the occurrence of discomfort and high fever-based complications. This study primarily sets out to observe and compare the efficacy of intravenous administration of paracetamol and ibuprofen drugs on fever in adult patients with tonsillopharyngitis. METHODS: This study was performed in a prospective, randomized controlled, double-blind design. The study population was divided as Group 1 (treated with paracetamol) and as Group 2 (treated with ibuprofen). While the first group was treated with paracetamol as 1000 mg in 150 ml normal saline, the second group was treated with ibuprofen as 400 mg in 150 ml normal saline. The primary outcome was the decrease in fever at 15, 30, and 60 min, while the secondary outcome was the need for additional treatment after 60 min. RESULTS: One hundred and eighty-five patients were included in the final analysis. The mean age of the paracetamol group (57.4% male) was 28.36 ± 9.6, whereas that of the ibuprofen group (54.9% male) was 27.45 ± 7.98. Fever was reduced significantly between 0 and 60 min in both groups (P ≤ 0.001 and P ≤ 0.001, respectively). Although the antipyretic effect of ibuprofen was more pronounced in the early period than that of paracetamol, no significant difference was noted between the two groups in terms of fever drop between 0 and 60 min (P = 0.350). CONCLUSION: Although both drugs prove effective in controlling fever at the 60 min, stronger efficacy of ibuprofen in the first 15 min may enable rapid discharge from the emergency department.